hepatocellular-carcinoma

Documents about hepatocellular-carcinoma

• AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway.#265561NCBI PubMed Central
• A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence#268025ClinicalTrials.gov
• Comprehensive multi-omics analysis identifies cancer subtypes and prognostic signatures of hepatitis B virus-associated hepatocellular carcinoma.#288711NCBI PubMed Central
• Effects of mindfulness-based stress reduction on perioperative outcomes in patients with advanced hepatocellular carcinoma undergoing transarterial chemoembolization.#323139NCBI PubMed Central
• AI-guided automated identification of patients at high risk for hepatocellular carcinoma in large US and global datasets.#334802NCBI PubMed Central
• Clinical Value of Inflammatory Indexes in Predicting Post-Transplantation Prognosis in Hepatocellular Carcinoma: A Retrospective Cohort Study.#351487NCBI PubMed Central
• GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC#366579ClinicalTrials.gov
• Diagnostic accuracy of surveillance tests for hepatocellular carcinoma in cirrhosis: a systematic review and network meta-analysis.#389026NCBI PubMed Central
• Hepatitis D Virus: Enigmas and Gaps of Knowledge#448793HAL (France)
• Molecular And Cellular Analysis Of Hepg2 Hepatocellular Carcinoma Upon Deubiquitin Enzymes Otub1 And Otub2 Knockdown#466856USM Repository
• Multi-Omics and Molecular Simulation Identify KIF11 as a Candidate Direct Target of Resveratrol in Hepatocellular Carcinoma.#625945NCBI PubMed Central
• High-fat diet-responsive DNM1 promotes hepatocellular carcinoma progression and predicts poor prognosis in viral-associated patients.#685606NCBI PubMed Central
• Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents#806676ClinicalTrials.gov
• Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea#838453ClinicalTrials.gov
• Pembrolizumab Plus Y90 Radioembolization in HCC Subjects#846917ClinicalTrials.gov
• A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy#863530ClinicalTrials.gov
• bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC#872246ClinicalTrials.gov
• Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation#877173ClinicalTrials.gov
• Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO#141014ClinicalTrials.gov
• Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms#888960ClinicalTrials.gov
• Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study#836745ClinicalTrials.gov
• Astaxanthin suppresses hepatocellular carcinoma via targeting Wnt/Β-catenin pathway: Experimental study on chemically induced HCC in rats.#122880NCBI PubMed Central
• LGALS3BP Links Centrosomes and Mitochondria to Maintain Energetic Fitness and Restrain Compensatory Lipid Catabolic Reprogramming in Hepatocellular Carcinoma.#150148NCBI PubMed Central
• Fenugreek seed extract-doxorubicin synergy against hepatocellular carcinoma in HepG2 cells: in vitro and in silico mechanistic studies.#161892NCBI PubMed Central
• IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8(+) T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression.#174624NCBI PubMed Central
• Complexes of Pentagamavunon-1 and Lactosylated Albumin for Enhancing the Cytotoxic Effect on Hepatocellular Carcinoma#194485Indonesian Journal of Pharmacy
• Spleen-targeted neoantigen mRNA vaccine induces ISG15(+) CD8(+) T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinoma.#223010NCBI PubMed Central
• Integrating spatial and single-cell transcriptomics via machine learning to characterize efferocytosis in hepatocellular carcinoma prognosis and immunotherapy.#227790NCBI PubMed Central
• Mechanism exploration of di(2-ethylhexyl) phthalate (DEHP)-induced hepatocellular carcinoma via network toxicology and molecular docking analysis.#239724NCBI PubMed Central
• Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation#297004IRIS
• Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B Virus#350017ClinicalTrials.gov
• SPP1+ Macrophages Promote Immunosuppression in Post-TACE Hepatocellular Carcinoma Involving Lactate-Induced Lactylation and Potential SPP1-CD44 Signaling.#364646NCBI PubMed Central
• BIOACTIVE COFFEE COMPOUNDS SYNERGISTICALLY ENHANCE THE ANTITUMOR EFFECTS OF CHEMO AND IMMUNOTHERAPY FOR HEPATOCELLULAR CARCINOMA IN VITRO#365218Repositório Institucional Unesp
• Prognostic and therapeutic implications of PSMD14 in hepatocellular carcinoma: an integrative analysis of transcriptomic and single-cell profiles.#368062NCBI PubMed Central
• Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure#373582ClinicalTrials.gov
• A reproducible ultrasound localization microscopy framework for the quantitative imaging of hepatocellular carcinoma on a clinical ultrasound system.#433956NCBI PubMed Central
• Supplemental Material for: Curative Locoregional Therapy Following Objective Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma#445387Figshare
• A six-gene prognostic signature for aflatoxin B1-associated hepatocellular carcinoma identified through integrated bioinformatics and network toxicology.#452832NCBI PubMed Central
• Machine Learning Model Integrating Clinical Features, CT Radiomics, and Transfer Learning for Predicting Aggressive Recurrence of Hepatocellular Carcinoma#634993Europe PMC
• Mitochondrial Quality Regulation Genes as Prognostic Markers in Hepatocellular Carcinoma: Tumor Microenvironment, Therapeutic Response, and Drug Sensitivity Analysis.#645280NCBI PubMed Central
• The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia.#645519NCBI PubMed Central
• A CECT-Based 2PI System as a Novel Noninvasive Prognostic Tool for Hepatocellular Carcinoma: A Dual-Validation Study.#662721NCBI PubMed Central
• Immunological characteristics of calmodulin-related genes in hepatocellular carcinoma and their potential for prognostic prediction and diagnostic applications.#666099NCBI PubMed Central
• Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant#812289ClinicalTrials.gov
• STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTs#829433ClinicalTrials.gov
• CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency Ablation#830578ClinicalTrials.gov
• HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC#834457ClinicalTrials.gov
• A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer#837648ClinicalTrials.gov
• Neoadjuvant Tislelizumab-Lenvatinib vs Surgery Alone in Stage Ia HCC With Narrow Margin#849479ClinicalTrials.gov
• Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC#849642ClinicalTrials.gov